Quantification of B cell subsets based on IgD and CD27 expression (Figure 1B) revealed no significant differences in the frequencies of naïve, unswitched memory, switched memory, or DN B cells between AChR-MG, rituximab-naïve MuSK-MG, and control subjects (Figure 1C). The gene discussed is CD27; the disease is myasthenia gravis.